Table 5.
Baseline characteristics of patients by nephrology consultation
Nephrology consult, RUS recommended (%, n=95) | Nephrology consult, RUS not recommended (%, n=73) | No nephrology consult (%, n=113) | P value | |
Sociodemographics | ||||
Age | ||||
18–39 | 12 | 7 | 9 | 0.70 |
40–59 | 23 | 26 | 23 | |
60–74 | 41 | 37 | 34 | |
≥75 | 24 | 30 | 35 | |
Sex | ||||
Male | 56 | 56 | 58 | 0.92 |
Female | 44 | 44 | 42 | |
Race/ethnicity | ||||
Non-Hispanic white | 28 | 22 | 20 | 0.30 |
Non-Hispanic black | 31 | 36 | 44 | |
Hispanic | 28 | 34 | 23 | |
Other | 13 | 8 | 12 | |
Risk criteria | ||||
History of hydronephrosis | 9 | 10 | 12 | 0.75 |
Non-black race | 69 | 64 | 56 | 0.12 |
History of recurrent UTIs | 1 | 4 | 17 | <0.001* |
Diagnosis consistent with possible obstruction | 40 | 45 | 50 | 0.39 |
Absence of nephrotoxins | 39 | 37 | 44 | 0.57 |
Absence of CHF | 67 | 77 | 78 | 0.19 |
Absence of prerenal AKI | 68 | 60 | 66 | 0.53 |
Laboratory results | ||||
Creatinine at admission, mean (SD) | 5.2 (4.4) | 4.0 (3.6) | 2.2 (1.6) | <0.001* |
Baseline creatinine, mean (SD) | 2.3 (1.4) | 2.0 (1.4) | 1.3 (0.7) | <0.001* |
χ2 tests were used to compare whether categorical variables differed by nephrology consultation status. Analysis of variance tests were used to compare whether continuous variables (laboratory values) differed by nephrology consultation status.
*Statistically significant at p<0.05.
AKI, acute kidney injury; CHF, congestive heart failure; RUS, renal ultrasound; UTIs, urinary tract infections.